Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III studies of faricimab in DME meet primary endpoint

Dec. 21, 2020

FDA issues EUA for Moderna's mRNA-1273 for COVID-19

Dec. 21, 2020

FDA approves Orgovyx for advanced prostate cancer

Dec. 21, 2020

Soricimed to explore utility of SOR-C13 for COVID-19

Dec. 21, 2020

Tumors, metastases activate mTOR in different ways

Dec. 21, 2020

Triumeq shown to slow down progression of MND in mice

Dec. 21, 2020

Preliminary phase I/II data for ZN-c5 monotherapy in ER-positive/HER2-negative breast cancer

Dec. 21, 2020

University of California, Oakland patents modified ZIVK-based products for cancer

Dec. 21, 2020

Korea Pharma describes JAK1 inhibitors

Dec. 21, 2020

Kallyope identifies new FFAR1 agonists

Dec. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...